Prognostic value of class III b-tubulin (TUBB3) in operable non-small cell lung cancer (NSCLC) and predictive value for adjuvant cisplatin-based chemotherapy (CT): A validation study on three randomized trials

被引：3

作者：

Reiman, T.

Seve, P.

Vataire, A.

Dunant, A.

Rosell, R.

Graziano, S.

Seymour, L.

Pirker, R.

Lai, R.

机构：

[1] Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada

[2] Univ Lyon 1, Hosp Civils Lyon, F-69365 Lyon, France

[3] Inst Gustave Roussy, Villejuif, France

[4] Catalan Inst Oncol, Barcelona, Spain

[5] SUNY Syracuse, Syracuse, NY USA

[6] Queens Univ, Kingston, ON, Canada

[7] Med Univ Vienna, Vienna, Austria

来源：

关键词：

D O I：

10.1200/jco.2008.26.15_suppl.7506

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

7506

引用

页数：1